Internal Medicine, Nephrology · Odessa, TX
NPI
1780892760
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
410 N Hancock Ave
Odessa, TX, 79761
Phone (432) 279-0905
Groups this clinician bills Medicare through
Medicare paid, 2024
$515K
5,671 services
Medicare patients, 2024
791
Average age 72
Drug cost, 2024
$1.9M
6,047 prescriptions
Company payments, 2025
$164K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anand C Reddy was code 99232 (hospital e&m - subsequent), 1,445 times for 325 patients. In total Anand C Reddy billed 5,671 services in 29 codes, and Medicare paid $515K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,445 | 325 | $58.60 | $85K |
| 99214 Office E&M - Established | Office | 700 | 339 | $82.25 | $58K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 678 | 331 | $11.85 | $8,034 |
| 90960 ESRD Related Services (not dialysis) | Office | 544 | 97 | $248.66 | $135K |
| 90935 Hemodialysis | Facility | 380 | 95 | $52.22 | $20K |
| 99223 Hospital E&M - Initial | Facility | 362 | 279 | $125.71 | $46K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 333 | 83 | $47.74 | $16K |
| 90961 ESRD Related Services (not dialysis) | Office | 244 | 88 | $213.90 | $52K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 205 | 83 | $36.47 | $7,476 |
| 99215 Office E&M - Established | Office | 179 | 117 | $124.79 | $22K |
| 90966 ESRD Related Services (not dialysis) | Office | 70 | 17 | $211.38 | $15K |
| 99204 Office E&M - New | Office | 70 | 70 | $120.03 | $8,402 |
| 90960 ESRD Related Services (not dialysis) | Facility | 65 | 20 | $267.81 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 48 | 31 | $85.65 | $4,111 |
| 99222 Hospital E&M - Initial | Facility | 33 | 27 | $98.96 | $3,266 |
By year: 2022 $601K for 5,120 services; 2023 $492K for 4,828 services; 2024 $515K for 5,671 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anand C Reddy prescribed most often to Medicare patients was Losartan Potassium, with 424 prescriptions and refills. In total Anand C Reddy wrote 6,047 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 424 | 813 | 123 | $2,866 |
| Carvedilol Generic | 306 | 563 | 105 | $1,405 |
| Allopurinol Generic | 274 | 499 | 78 | $2,093 |
| Jardiance Empagliflozin | 268 | 343 | 66 | $195K |
| Rayaldee Calcifediol | 259 | 261 | 48 | $338K |
| Amlodipine Besylate Generic | 241 | 407 | 71 | $677 |
| Bumetanide Generic | 173 | 241 | 56 | $5,552 |
| Sevelamer Carbonate Generic | 163 | 209 | 51 | $42K |
| Clonidine Hcl Generic | 155 | 203 | 41 | $849 |
| Pantoprazole Sodium Generic | 155 | 256 | 54 | $1,173 |
| Spironolactone Generic | 137 | 211 | 39 | $884 |
| Hydralazine Hcl Generic | 132 | 212 | 44 | $1,440 |
| Terazosin Hcl Generic | 131 | 185 | 39 | $750 |
| Calcitriol Generic | 125 | 168 | 28 | $1,391 |
| Velphoro Sucroferric Oxyhydroxide | 122 | 138 | 31 | $417K |
Brand drugs: 1,510 claims; generic drugs: 4,521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anand C Reddy $164K ($163K in general payments such as food, travel and fees and $282 for research) from 19 companies. The largest payer was Travere Therapeutics, Inc. with $41K.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 96 | $41K |
| Calliditas Therapeutics US Inc. | 41 | $29K |
| Amgen Inc. AMGN | 34 | $22K |
| Ardelyx, Inc. ARDX | 15 | $19K |
| Akebia Therapeutics Inc AKBA | 21 | $15K |
| Scpharmaceuticals Inc. SCPH | 17 | $9,955 |
| ANI Pharmaceuticals, Inc. ANIP | 9 | $9,050 |
| Lilly USA, LLC LLY | 12 | $8,899 |
| American Regent | 1 | $4,160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 22 | $3,899 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.